SEARCH
CorbeVax Booster Vaccine-ஐ 18 வயதுக்கு மேற்பட்டவர்களும் செலுத்தலாம் | Covid Vaccine
Oneindia Tamil
2022-08-10
Views
1
Description
Share / Embed
Download This Video
Report
#CovidVaccine
#BoosterVaccine
#CorbeVax
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x8cyk5g" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
01:37
Covishield at Rs 780, Covaxin Rs 1410, Sputnik At Rs 1145: COVID Vaccine Prices Capped For Pvt Hosps
01:37
Covishield at Rs 780, Covaxin Rs 1410, Sputnik At Rs 1145: COVID Vaccine Prices Capped For Pvt Hosps
02:36
Higit 132-K doses ng Sputnik V COVID-19 vaccine, nasa bansa na; higit 30-K doses, darating ngayong gabi; Russian Amb. to the PHL, iginiit na simbolo ng matatag na relasyon ng Russia at PHL ang patuloy na vaccine delivery ng Sputnik V
03:58
भारतातील ३ लसींपैकी कोणती लस चांगली? Which Vaccine Is Better In India? Covaxin | Covishield |Sputnik
01:41
COVID-19 Vaccine : Coronavirus Vaccine Sputnik V 92% Effective Against COVID-19 - Russia
03:33
covishield आणि Phizer बाबत | Astrazeneca Vaccine | Corona Vaccine | Covid 19
01:05
India Approves 2 COVID-19 Vaccines: Covaxin, Covishield Vaccines 110% सुरक्षित
01:41
Which COVID-19 Vaccine You Have Taken? Amid Covishield Controversy, Here's How To Check Name Of Vaccine Administered To You
02:51
Higit 16-M doses ng COVID-19 vaccines, inaasahang darating sa bansa ngayong Setyembre; Desisyon sa pagbabakuna ng booster shots, posibleng ilabas ng vaccine expert panel sa susunod na linggo; 3rd dose ng bakuna vs. COVID-19, pwedeng ibigay sa healthcare w
03:12
Putin offers to give Erdogan a Sputnik vaccine booster after meeting in Russia
05:29
COVID-19 Vaccine Update: Sputnik V To Undergo Trial In India, Dr Reddys Gets DCGI Approval, Serum Institute, Bharat Biotech To Start Intranasal Vaccine Trials
12:46
Russia's COVID Vaccine Sputnik V is 91.6% Effective against Symptomatic Covid-19